B. Metzler Seel. Sohn & Co. Ag Natera, Inc. Transaction History
B. Metzler Seel. Sohn & Co. Ag
- $9.49 Billion
- Q2 2024
A detailed history of B. Metzler Seel. Sohn & Co. Ag transactions in Natera, Inc. stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Ag holds 13,028 shares of NTRA stock, worth $1.66 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,028
Previous 13,028
-0.0%
Holding current value
$1.66 Million
Previous $1.19 Million
18.39%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding NTRA
# of Institutions
504Shares Held
120MCall Options Held
412KPut Options Held
270K-
Vanguard Group Inc Valley Forge, PA11.3MShares$1.43 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$861 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY6.07MShares$772 Million0.06% of portfolio
-
Fred Alger Management, LLC New York, NY5.26MShares$669 Million2.83% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.46MShares$567 Million2.34% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $12.3B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...